福元医药
(601089)
| 流通市值：31.58亿 | | | 总市值：73.82亿 |
| 流通股本：2.05亿 | | | 总股本：4.80亿 |
| 报告期 | 2024-09-30 | 2024-06-30 | 2024-03-31 | 2023-12-31 |
| 公司类型 | 通用 | 通用 | 通用 | 通用 |
| 流动资产: | | | | |
| 货币资金 | 974,094,073.63 | 1,240,999,787.72 | 2,421,964,605.09 | 2,530,809,346 |
| 应收票据及应收账款 | 347,584,668.1 | 344,184,813.03 | 334,080,231.03 | 346,134,907.22 |
| 应收账款 | 347,584,668.1 | 344,184,813.03 | 334,080,231.03 | 346,134,907.22 |
| 应收款项融资 | 86,844,068 | 72,210,098.42 | 70,328,802.87 | 98,440,759.42 |
| 预付款项 | 32,700,471.46 | 32,768,358.4 | 46,259,419.61 | 41,698,624.51 |
| 其他应收款合计 | 1,553,590.05 | 1,754,566.52 | 2,393,585.98 | 1,792,213.18 |
| 存货 | 344,014,911.9 | 336,048,032.45 | 329,509,170.73 | 307,419,355.37 |
| 其他流动资产 | 3,760,973.23 | 2,694,172.01 | 2,884,977.95 | 2,445,359.11 |
| 流动资产平衡项目 | 0 | 0 | 0 | 0 |
| 流动资产合计 | 3,118,552,756.37 | 3,090,659,828.55 | 3,207,420,793.26 | 3,328,740,564.81 |
| 非流动资产: | | | | |
| 固定资产 | 670,454,627.99 | 677,698,851.17 | 683,174,221.11 | 678,544,711.16 |
| 在建工程 | 507,678,552.93 | 361,220,548.73 | 286,144,341.53 | 255,657,249.32 |
| 使用权资产 | 36,552,922.69 | 40,469,328.32 | 44,839,498.26 | 49,209,809.36 |
| 无形资产 | 141,367,473.81 | 144,460,016.35 | 147,175,130.16 | 150,197,426.51 |
| 长期待摊费用 | 20,642,104.76 | 22,265,327.22 | 23,738,668.52 | 22,923,850.62 |
| 递延所得税资产 | 2,466,118.04 | 2,432,497.39 | 2,484,647.61 | 2,807,905.2 |
| 其他非流动资产 | 38,939,446.49 | 97,631,429.65 | 98,931,907.32 | 59,708,784.81 |
| 非流动资产平衡项目 | 0 | 0 | 0 | 0 |
| 非流动资产合计 | 1,418,101,246.71 | 1,346,177,998.83 | 1,286,488,414.51 | 1,219,049,736.98 |
| 资产平衡项目 | 0 | 0 | 0 | 0 |
| 资产总计 | 4,536,654,003.08 | 4,436,837,827.38 | 4,493,909,207.77 | 4,547,790,301.79 |
| 流动负债: | | | | |
| 短期借款 | 49,938,269.45 | 49,939,102.78 | 49,940,070 | 55,050,513.92 |
| 应付票据及应付账款 | 140,214,823.65 | 127,443,210.13 | 119,020,432.14 | 132,178,897.79 |
| 应付账款 | 140,214,823.65 | 127,443,210.13 | 119,020,432.14 | 132,178,897.79 |
| 预收款项 | 492,973.1 | 517,398.09 | 514,521.22 | 78,850 |
| 合同负债 | 53,741,648.2 | 74,082,798.09 | 64,780,124.77 | 39,743,326.9 |
| 应付职工薪酬 | 125,542,446.75 | 102,926,745.2 | 73,952,167.66 | 135,737,991.52 |
| 应交税费 | 36,411,812.78 | 29,757,609.61 | 36,241,886.14 | 42,990,787.03 |
| 其他应付款合计 | 567,807,808.03 | 553,043,330.43 | 565,125,331.5 | 537,491,861.57 |
| 一年内到期的非流动负债 | 15,287,658.04 | 21,600,399.23 | 22,804,723.24 | 24,612,808.6 |
| 其他流动负债 | 28,695,277.88 | 27,868,741.29 | 31,477,556.45 | 30,490,525.54 |
| 流动负债平衡项目 | 0 | 0 | 0 | 0 |
| 流动负债合计 | 1,018,132,717.88 | 987,179,334.85 | 963,856,813.12 | 998,375,562.87 |
| 非流动负债: | | | | |
| 长期借款 | - | 9,898,088.82 | 12,372,611.02 | 12,373,544.87 |
| 租赁负债 | 21,713,117.63 | 26,026,008.74 | 27,787,169.66 | 32,262,214.12 |
| 递延收益 | 9,537,471.78 | 9,863,155.44 | 10,188,839.1 | 10,016,356.09 |
| 递延所得税负债 | 19,165,794.14 | 18,753,193.91 | 18,447,950.04 | 18,223,517.79 |
| 非流动负债平衡项目 | 0 | 0 | 0 | 0 |
| 非流动负债合计 | 50,416,383.55 | 64,540,446.91 | 68,796,569.82 | 72,875,632.87 |
| 负债平衡项目 | 0 | 0 | 0 | 0 |
| 负债合计 | 1,068,549,101.43 | 1,051,719,781.76 | 1,032,653,382.94 | 1,071,251,195.74 |
| 所有者权益(或股东权益): | | | | |
| 实收资本(或股本) | 480,000,000 | 480,000,000 | 480,000,000 | 480,000,000 |
| 资本公积 | 1,662,392,718.51 | 1,662,392,718.51 | 1,662,392,718.51 | 1,662,392,718.51 |
| 减:库存股 | 176,186,608.79 | 148,626,645.16 | 148,626,645.16 | - |
| 专项储备 | 10,997,433.02 | 12,093,136.51 | 12,154,057.09 | 12,335,279.75 |
| 盈余公积 | 154,181,999.35 | 154,181,999.35 | 154,181,999.35 | 154,181,999.35 |
| 未分配利润 | 1,325,465,344.59 | 1,215,136,731.73 | 1,292,083,730.89 | 1,159,506,439.29 |
| 归属于母公司股东权益平衡项目 | 0 | 0 | 0 | 0 |
| 归属于母公司股东权益合计 | 3,456,850,886.68 | 3,375,177,940.94 | 3,452,185,860.68 | 3,468,416,436.9 |
| 少数股东权益 | 11,254,014.97 | 9,940,104.68 | 9,069,964.15 | 8,122,669.15 |
| 股东权益平衡项目 | 0 | 0 | 0 | 0 |
| 股东权益合计 | 3,468,104,901.65 | 3,385,118,045.62 | 3,461,255,824.83 | 3,476,539,106.05 |
| 负债和股东权益合计 | 4,536,654,003.08 | 4,436,837,827.38 | 4,493,909,207.77 | 4,547,790,301.79 |
| 公告日期 | 2024-10-25 | 2024-08-15 | 2024-04-24 | 2024-04-01 |
| 审计意见(境内) | | | | 标准无保留意见 |